Prolia® is a powerful tool in the battle against osteoporosis – a condition causing bones to weaken and become more susceptible to fractures. Factors like age, post-menopause (in women), family history of osteoporosis, and prolonged use of certain medications can elevate the risk of osteoporosis development.

Toujeo Max, a long-acting insulin formulated as a sterile solution for subcutaneous injection, boasting a concentration of 300 units/mL. Crafted through innovative recombinant DNA technology, Insulin Glargine originates from a non-pathogenic Escherichia coli laboratory strain.